BeiGene, Ltd. Files 8-K on Sept 30, 2024

TL;DR

BeiGene filed an 8-K on 9/30/24, standard corporate update.

AI Summary

BeiGene, Ltd. filed an 8-K on September 30, 2024, reporting other events and financial statements. The filing details the company's corporate information, including its incorporation in the Cayman Islands and principal executive offices located in Grand Cayman.

Why It Matters

This filing serves as an official record of BeiGene's corporate activities and financial reporting, providing transparency to investors and stakeholders.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that suggests a significant change in risk for the company.

Key Players & Entities

• BeiGene, Ltd. (company) — Registrant
• Cayman Islands (company) — Jurisdiction of Incorporation
• Mourant Governance Services (Cayman) Limited (company) — Agent for Service of Process
• September 30, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.0001 — resenting 13 Ordinary Shares, par value $0.0001 per share BGNE The NASDAQ Global Sele

Filing Documents

• bgne-20240930.htm (8-K) — 35KB
• a20240930formxupdatedriskf.htm (EX-99.1) — 405KB
• 0001651308-24-000123.txt ( ) — 675KB
• bgne-20240930.xsd (EX-101.SCH) — 2KB
• bgne-20240930_lab.xml (EX-101.LAB) — 21KB
• bgne-20240930_pre.xml (EX-101.PRE) — 12KB
• bgne-20240930_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events. On July 25, 2024, BeiGene, Ltd. (the "Company") received a comment letter from the staff of the Division of Corporation Finance (the "Staff") of the U.S. Securities and Exchange Commission requesting that we restore certain risk factors disclosure related to legal and operational risks associated with our operations in China to the language previously contained in our annual report on Form 10-K for the year ended December 31, 2022. In response to the Staff's comment, we are filing this Current Report on Form 8-K to update and restate the risk factors discussed under the section captioned "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, as well as any updates to those risk factors or new risk factors contained in our subsequent Quarterly Reports on Form 10-Q. The updated and restated risk factors are filed herewith as Exhibit 99.1 and incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Updated and Restated Risk Factors 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL Exhibit Index Exhibit No. Description 99.1 Updated and Restated Risk Factors 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEIGENE, LTD. Date: September 30, 2024 By: /s/ Chan Lee Name: Chan Lee Title: Senior Vice President, General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR